Pfizer Had Clues Its Blockbuster Drug Could Prevent Alzheimer’s. Why Didn’t It Tell the World?
Pfizer Had Clues Its Blockbuster Drug Could Prevent Alzheimer’s. Why Didn’t It Tell the World?
A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease by 64 percent.